This is one of the more important and underappreciated findings in nutritional science from the past two decades. And it is routinely ignored in how most D3 supplements are formulated.

Vitamin D3’s primary mechanism is increasing calcium absorption from the gut. It activates a transport protein that moves calcium from the intestinal lumen into the bloodstream — a well-established, necessary function for bone health. The problem is what happens to that calcium next.

Where Calcium Goes Without K2

Calcium in the blood needs a destination. The two most common options are bone — where it belongs — and the walls of arteries and soft tissue — where it causes harm.

Vitamin K2 determines which of those destinations calcium reaches, through two proteins it activates.

Osteocalcin is produced by bone-forming cells. In its inactive form, it cannot bind calcium. K2 carboxylates osteocalcin — switches it to its active form — so it can pull calcium into bone matrix. Without K2, osteocalcin remains inactive regardless of how much calcium is circulating.

Matrix GLA Protein (MGP) is the body’s primary defence against arterial calcification. Found in vascular smooth muscle cells, its job is to inhibit calcium deposits in artery walls. It also requires K2 to activate. Without K2, MGP cannot perform this protective function.

When D3 is adequate but K2 is deficient, the sequence runs like this: calcium absorption increases, osteocalcin is too inactive to incorporate it into bone, and MGP is too inactive to keep it out of arteries. The calcium ends up where you do not want it.

The Rotterdam Study

The most significant population evidence for this mechanism comes from the Rotterdam Study — a 10-year prospective study of 4,807 individuals, published in the Journal of Nutrition (Geleijnse et al., 2004).

Participants in the highest tertile of K2 intake showed a 57% lower risk of dying from heart disease and a 52% lower rate of severe aortic calcification compared to those in the lowest tertile.

These associations were specific to K2, particularly MK-7 form — not K1, which is the form found in leafy green vegetables and primarily involved in blood coagulation. Dietary K1 intake does not substitute for K2.

The India Context

Cardiovascular disease accounts for over 25% of all mortality in India, according to Global Burden of Disease data. Arterial calcification is a major contributing factor — progressive, largely silent until a cardiac event occurs.

India’s dietary K2 intake is low. K2 is found in meaningful amounts primarily in fermented foods — natto (exceptionally high in MK-7), certain aged cheeses, and grass-fed dairy. Natto is a Japanese staple; it is not part of Indian food culture. Traditional Indian fermented foods like idli, dosa, and fermented pickles contain trace amounts but are not considered significant K2 sources.

For a population where D3 deficiency is both prevalent and increasingly addressed through supplementation, the absence of K2 alongside D3 is a real concern that most products do not acknowledge.

Why MK-7 Specifically

K2 supplements come primarily in MK-4 and MK-7 forms. The pharmacokinetic difference between them is substantial.

MK-4 has a blood half-life of approximately 1–2 hours, documented in a study published in Blood (Schurgers et al., 2007). It clears the system quickly. A single daily dose of MK-4 provides coverage for a few hours.

MK-7 has a half-life of approximately 72 hours. A single daily dose maintains consistent K2-dependent protein activation throughout the day and night — including continuous MGP activation in vascular tissue, which requires sustained K2 levels to function.

Frequently Asked Questions

If I have been taking D3 without K2 for years, should I be worried?
Difficult to assess without imaging such as a coronary artery calcium scan. The mechanism is real and the Rotterdam Study documents population-level differences. Adding K2 is a reasonable step. If cardiovascular risk is a concern, speak with your doctor.

Does K2 interact with blood thinners?
Yes. K2 is involved in coagulation pathways and can affect warfarin activity. Anyone on warfarin should consult their prescribing doctor before adding K2. Newer anticoagulants (rivaroxaban, apixaban) do not interact in the same way.

Does eating leafy greens give me enough K2?
No. Leafy greens are rich in K1, which handles coagulation. The body converts very little K1 to K2. Dietary K1 does not meaningfully address arterial calcification or osteocalcin activation.

How much MK-7 do I need?
There is no established ICMR RDA for K2. Clinical research on bone and arterial outcomes has used 45–180mcg MK-7 per day. A daily dose of 55–90mcg alongside D3 is an evidence-based range for healthy adults.

Does K2 help build more bone, or just prevent arterial calcification?
Both. A 2013 meta-analysis in Osteoporosis International found significant reductions in vertebral fracture risk with K2 supplementation versus control groups. The mechanism is osteocalcin carboxylation — more active osteocalcin, more efficient calcium incorporation into bone.